Summer Sale
50% off Premium Yearly
Opinions Lyle Stein
Horizon's Medical MarijuanaHMMJ.TOCOMMENTJun 27, 2017
Stock price when the opinion was issued
As of Jun 19, 2026. Market Open.
You might be interested:
This asset class has been down for 5 years during a long period of investor apathy. But when an asset class has been down for longer than 3 years, you start to consider it. HMMJ has US exposure where there is growing public support for legalizing canopy. Maybe start with a small position. This is a volatile sector.
HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.
Something he is not looking at closely. The rise in marijuana stocks is new, and reminds him a lot of the rise of some of the emerging technology stocks back in 1999. It may pay off well, but the industry is so uncertain at this point. The rules on marijuana have yet to be put in place. This is a trader’s vehicle, not necessarily an investor’s vehicle. Not an area he would be investing in.